‘Advanced Testing to cut patient costs, delays’
Irfan Tramboo
SRINAGAR, Mar 9: Sher-e-Kashmir Institute of Medical Sciences (SKIMS) today inaugurated a comprehensive panel of 174 Immunohistochemistry (IHC) markers at its Department of Pathology.
As per officials, the move is aimed at strengthening advanced cancer diagnostics and precision pathology services at the institute.
They said that the introduction of the extensive IHC panel will significantly enhance the institute’s diagnostic capabilities by enabling more accurate tumor classification, improved prognostication and better-informed therapeutic decision-making for a wide range of malignancies and other complex diseases.
The facility was inaugurated by Director SKIMS Prof. M. Ashraf Ganie, at the Immunohistochemistry Laboratory of the Department of Pathology.
The event was attended by faculty members, residents and technical staff of the department, along with faculty from Medical Oncology, Surgical Oncology, Radiation Oncology, general surgery and Clinical Hematology.
Speaking on the occasion, Prof. Ganie congratulated the Department of Pathology for establishing the expanded diagnostic panel and said the initiative would strengthen the institute’s capacity to deliver advanced diagnostic services to patients across J&K and neighbouring regions.
He said the availability of advanced immunohistochemical testing within the institute would reduce the need for patients to send samples outside the region, saving both time and cost while facilitating timely initiation of treatment.
The Director also highlighted the importance of inter-departmental collaboration in improving diagnostic efficiency, particularly in the management of cancer cases where timely and accurate pathological diagnosis plays a critical role in patient care.
Head of the Department of Pathology, Dr. Syed Besina, said the expanded IHC panel includes markers required for the diagnosis and subtyping of hematolymphoid, epithelial, mesenchymal and neuroendocrine tumors, as well as several prognostic and predictive markers increasingly used in modern oncology practice.
He added that the facility will also support academic research and postgraduate training by providing enhanced learning opportunities for residents and researchers in pathology.
Follow our WhatsApp channel
